C
Cabaletta Bio, Inc. (CABA)
NMS – Real Time Price. Currency in USD
3.63
-0.19 (-4.97%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
3.63
-0.19 (-4.97%)
At close: May 12, 2026, 4:00 PM EDT
Revenue breakdown data has not been calculated yet.
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 2.77 | 6.05 | 10 | |
| Quick ratio | 2.77 | 5.63 | 10 | |
| Debt to Equity | 0.24 | 0.30 | 8.0 | |
| Debt to Assets | 0.16 | 1.04 | 8.0 | |
| Interest coverage | -76.78 | -16.91 | 1.0 | |
| Weighted average score | 7.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | -4M | -1M | -5M | -2M | -2M |
| Operating Income | -54M | -75M | -125M | -172M | -172M |
| Net Income | -53M | -68M | -116M | -168M | -168M |
| EBITDA | -50M | -73M | -120M | -171M | -171M |
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Gross margin % | N/A | -11.73 | 1.0 | |
| Operating margin % | N/A | -24.60 | 1.0 | |
| Net margin % | N/A | -172.20 | 1.0 | |
| EBITDA margin % | N/A | -201.27 | 1.0 | |
| Cash flow margin % | N/A | -156.39 | 1.0 | |
| Weighted average score | 1.0 | |||
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 43.61 | 5.5 |
| Next quarter | N/A | 41.37 | 5.5 |
| Current year | N/A | 24.23 | 5.5 |
| Next year | N/A | 3.4 | 2.5 |
| Weighted average score | 4.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | 6.57 | 9.09 | -2.77 | 5.5 |
| Y/Y | 999 | -28.63 | 38.46 | -51.27 | 5.5 |
| 3y average | 999 | -47.92 | -7.56 | -41.35 | 3.3 |
| 5y average | 999 | -39.4 | -9.64 | -38.23 | 3.3 |
| Weighted average score | 4.4 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Company's cash reserves $83.0M significantly exceed its total debt $27.1M, ensuring strong financial flexibility
Total current assets $138.9M exceed Total current liabilities $50.2M, highlighting excellent liquidity
Debt-to-equity ratio (0.2) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-76.8x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$35.5M limits the company's ability to reinvest or pay down debt